Selective adenosine A2Areceptor agonists and antagonists protect against spinal cord injury through peripheral and central effects
Authors:
- Irene PaternitiIPIrene Paterniti
- Alessia MelaniAMAlessia Melani
- Sara CiprianiSCSara Cipriani
- Francesca CortiFCFrancesca Corti
- Tommaso MelloTMTommaso Mello
- Emanuela MazzonEMEmanuela Mazzon
- Emanuela EspositoEEEmanuela Esposito
- Placido BramantiPBPlacido Bramanti
- Salvatore CuzzocreaSalvatore Cuzzocrea
- Felicita PedataFPFelicita Pedata
Open Access
- 12 April 2011
- journal article
- research article
- Published by Springer Nature in Journal of Neuroinflammation
- Vol. 8 (1) , 1-14
Abstract
Background: Permanent functional deficits following spinal cord injury (SCI) arise both from mechanical injury and from secondary tissue reactions involving inflammation. Enhanced release of adenosine and glutamate soon after SCI represents a component in the sequelae that may be responsible for resulting functional deficits. The role of adenosine A2Areceptor in central ischemia/trauma is still to be elucidated. In our previous studies we have demonstrated that the adenosine A2Areceptor-selective agonist CGS21680, systemically administered after SCI, protects from tissue damage, locomotor dysfunction and different inflammatory readouts. In this work we studied the effect of the adenosine A2Areceptor antagonist SCH58261, systemically administered after SCI, on the same parameters. We investigated the hypothesis that the main action mechanism of agonists and antagonists is at peripheral or central sites.Methods: Spinal trauma was induced by extradural compression of SC exposed via a four-level T5-T8 laminectomy in mouse. Three drug-dosing protocols were utilized: a short-term systemic administration by intraperitoneal injection, a chronic administration via osmotic minipump, and direct injection into the spinal cord.Results: SCH58261, systemically administered (0.01 mg/kg intraperitoneal. 1, 6 and 10 hours after SCI), reduced demyelination and levels of TNF-α, Fas-L, PAR, Bax expression and activation of JNK mitogen-activated protein kinase (MAPK) 24 hours after SCI. Chronic SCH58261 administration, by mini-osmotic pump delivery for 10 days, improved the neurological deficit up to 10 days after SCI. Adenosine A2Areceptors are physiologically expressed in the spinal cord by astrocytes, microglia and oligodendrocytes. Soon after SCI (24 hours), these receptors showed enhanced expression in neurons. Both the A2Aagonist and antagonist, administered intraperitoneally, reduced expression of the A2Areceptor, ruling out the possibility that the neuroprotective effects of the A2Aagonist are due to A2Areceptor desensitization. When the A2Aantagonist and agonist were centrally injected into injured SC, only SCH58261 appeared neuroprotective, while CGS21680 was ineffective.Conclusions: Our results indicate that the A2Aantagonist protects against SCI by acting on centrally located A2Areceptors. It is likely that blockade of A2Areceptors reduces excitotoxicity. In contrast, neuroprotection afforded by the A2Aagonist may be primarily due to peripheral effects.Keywords
This publication has 67 references indexed in Scilit:
- THE SELECTIVE ADENOSINE A2A RECEPTOR AGONIST CGS 21680 REDUCES JNK MAPK ACTIVATION IN OLIGODENDROCYTES IN INJURED SPINAL CORDShock, 2009
- Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotectionBritish Journal of Pharmacology, 2009
- Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activationJournal of Experimental Medicine, 2006
- Poly(ADP-Ribose) Glycohydrolase Activity Mediates Post-Traumatic Inflammatory Reaction after Experimental Spinal Cord TraumaThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Pharmacological Approaches To Repair the Injured Spinal CordJournal of Neurotrauma, 2006
- Modulation of nitric oxide homeostasis in a mouse model of spinal cord injuryJournal of Neurosurgery: Spine, 2006
- Perinatal white matter injury: The changing spectrum of pathology and emerging insights into pathogenetic mechanismsMental Retardation and Developmental Disabilities Research Reviews, 2006
- JNK activation contributes to DP5 induction and apoptosis following traumatic spinal cord injuryNeurobiology of Disease, 2005
- Peroxynitrite generated in the rat spinal cord induces oxidation and nitration of proteins: Reduction by Mn (III) tetrakis (4‐benzoic acid) porphyrinJournal of Neuroscience Research, 2002
- Pathophysiology of spinal cord traumaAnnals of Emergency Medicine, 1993